Life Science REIT (LON:LABS) Trading Down 1.2% – Should You Sell?

Life Science REIT plc (LON:LABS)’s stock price traded down 1.2% during trading on Friday . The company traded as low as GBX 41.50 ($0.56) and last traded at GBX 41.50 ($0.56). 416,151 shares were traded during trading, a decline of 49% from the average session volume of 808,089 shares. The stock had previously closed at GBX 42 ($0.57).

Life Science REIT Price Performance

The firm has a market capitalization of £147.34 million, a P/E ratio of -3.68 and a beta of 0.08. The business’s 50-day moving average is GBX 43.32 and its 200 day moving average is GBX 39.26.

Life Science REIT (LON:LABS) last released its quarterly earnings results on Wednesday, April 16th. The company reported GBX 1.70 ($0.02) EPS for the quarter. Life Science REIT had a negative net margin of 198.99% and a negative return on equity of 14.53%.

Life Science REIT Company Profile

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.